About: Improving Plasma Stability and Bioavailability In Vivo of Gemcitabine Via Nanoparticles of mPEG-PLG-GEM Complexed with Calcium Phosphate

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Improving Plasma Stability and Bioavailability In Vivo of Gemcitabine Via Nanoparticles of mPEG-PLG-GEM Complexed with Calcium Phosphate Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 11 October 2018

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2018 (fr) im Oktober 2018 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 2018 (ast) наукова стаття, опублікована в жовтні 2018 (uk) 2018 թվականի հոկտեմբերի 11-ին հրատարակված գիտական հոդված (hy) scientific article published on 11 October 2018 (en)
publication date	wds:Q57476679-2372833F-05FD-4779-9B24-078271FD0FB8
publication date	2018-10-11 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57476679-12963C11-FCD1-4EF5-B008-9759C5D18E0E
language of work or name	English
cites work	wds:Q57476679-1456654B-E1A0-4E6C-992D-F251FE7E95D9 wds:Q57476679-152E0741-B6BB-4EF4-8D0F-F046880B3D91 wds:Q57476679-1CECE926-2AAA-40F9-924B-05377B0A3C09 wds:Q57476679-314454BC-136E-45E1-A5A7-C1F88A05992A wds:Q57476679-35B06998-79DA-43A2-BE59-84ACA75DD6C1 wds:Q57476679-39FF429E-A2A4-4208-BEF4-3AC43D303E3B wds:Q57476679-3E0BAB61-8CB7-4C10-852B-A699D31540E1 wds:Q57476679-47F925BB-44BA-4755-8C75-3859E8E55984 wds:Q57476679-4AAEB172-E876-4518-9812-EBBD351DB7BF wds:Q57476679-4F461E0E-0D63-4587-BF35-92FBF6F5A96D wds:Q57476679-53234496-0255-48E7-9FAC-B12CB76DF45A wds:Q57476679-542FC545-CF9E-4808-B68E-6BEAC21A57D3 wds:Q57476679-57EF983B-6299-4F80-A7FA-77BA47F92C76 wds:Q57476679-6179D5B3-CEB8-4B1C-9DBA-B67ECA1C5591 wds:Q57476679-76754DFD-3BF6-4841-88B9-8C16AEE0C403 wds:Q57476679-81A28B51-BB24-4ECA-8296-C863930F1E04 wds:Q57476679-8931D153-73FA-42BE-8288-A97B6F76D9D7 wds:Q57476679-92619F3C-79BB-4799-A267-C7C86B4AAE0A wds:Q57476679-95416050-7504-419E-9CC5-18DD1339FF40 wds:Q57476679-98E0E90B-6FB2-413C-80FC-8943BC757AB9 wds:Q57476679-AAF87121-BD94-4AA2-A9AA-D321892DE403 wds:Q57476679-B333EE51-3D74-4AC2-B2B8-D0ACA2D4EBB5 wds:Q57476679-CFD96CD5-2760-47F8-9F24-D42544CD1F69 wds:Q57476679-DA9C15D2-6934-4F8E-905D-FB50BC85B10D wds:Q57476679-DC9B056D-2E3E-4EC0-9BFA-EE7E2652C870 wds:Q57476679-DD02D4BF-B530-4D3F-B337-DFA680961F53 wds:Q57476679-DDF766AD-C961-4BB4-934F-E5BEA9BD2993 wds:Q57476679-E156AC3A-6B76-4C97-B16D-724B7BD80119 wds:Q57476679-E95AD991-CBA3-4CC4-94EA-E8839A88A6D0 wds:Q57476679-FE76B075-D228-4C5D-8FE9-69AF1A101EC8 wds:Q57476679-FF3A1A4C-6D6F-4CA9-BA9D-4F5DC20CB979
cites work	Biodegradation and Toxicity of Protease/Redox/pH Stimuli-Responsive PEGlated PMAA Nanohydrogels for Targeting Drug delivery Cellular pharmacology of gemcitabine Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer Determinants of resistance to 2',2'-difluorodeoxycytidine (gemcitabine). Advanced breast cancer: a phase II trial with gemcitabine Advanced pancreatic carcinoma: current treatment and future challenges Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemia Cellular elimination of 2',2'-difluorodeoxycytidine 5'-triphosphate: a mechanism of self-potentiation Preclinical pharmacokinetic/pharmacodynamic models to predict schedule-dependent interaction between erlotinib and gemcitabine. Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery Proteinase-mediated drastic morphological change of peptide-amphiphile to induce supramolecular hydrogelation In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles Synthesis, cleavage profile, and antitumor efficacy of an albumin-binding prodrug of methotrexate that is cleaved by plasmin and cathepsin B. A phase I clinical, plasma, and cellular pharmacology study of gemcitabine Schedule dependence of sensitivity to 2',2'-difluorodeoxycytidine (Gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumours Clinical pharmacology and pharmacogenetics of gemcitabine Folate-mediated targeting of polymeric conjugates of gemcitabine. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy. Cisplatin Loaded Poly(L-glutamic acid)-g-Methoxy Poly(ethylene glycol) Complex Nanoparticles for Potential Cancer Therapy: Preparation, In Vitro and In Vivo Evaluation Lysosomal delivery of a lipophilic gemcitabine prodrug using novel acid-sensitive micelles improved its antitumor activity Systemic delivery of gemcitabine triphosphate via LCP nanoparticles for NSCLC and pancreatic cancer therapy Long circulation and cytotoxicity of PEGylated gemcitabine and its potential for the treatment of pancreatic cancer Physicochemical properties of pH-controlled polyion complex (PIC) micelles of poly(acrylic acid)-based double hydrophilic block copolymers and various polyamines. An improved simple LC-MS/MS method for the measurement of serum aripiprazole and its major metabolite. Lessons Learned from Gemcitabine: Impact of Therapeutic Carrier Systems and Gemcitabine's Drug Conjugates on Cancer Therapy Development of Long-Circulating pH-Sensitive Liposomes to Circumvent Gemcitabine Resistance in Pancreatic Cancer Cells Intracellular pharmacokinetics of gemcitabine, its deaminated metabolite 2',2'-difluorodeoxyuridine and their nucleotides. Recent advances in drug delivery strategies for improved therapeutic efficacy of gemcitabine. Pharmacokinetics, Metabolism, Distribution and Permeability of Nanomedicine
author name string	wds:Q57476679-2CCCF23B-9FA7-4201-8447-FB4092CA0C13 wds:Q57476679-4A95A12C-10BF-4FF7-AAD6-B77BCE7230AD wds:Q57476679-4AFE62B5-6F5C-4539-8ACE-352702B882A3 wds:Q57476679-57CB468C-BB42-4204-93F1-38595AB7B38C wds:Q57476679-678A68E2-7E1E-419A-9E78-8E2591BD868B wds:Q57476679-6D38D67B-F84C-4884-A68A-E0D489E92BF6 wds:Q57476679-7364E88E-A25F-4C06-8C0E-580249B7137F wds:Q57476679-744B7484-0A2C-44BD-9DD7-102C1B48415B wds:Q57476679-74951588-18BA-4518-8734-9FD4DFCF0328 wds:Q57476679-BA68871F-A76A-4A22-945F-130ADF3E9A27 wds:Q57476679-F67E1D86-8FEF-4B31-8E6B-9CB2317ECD4D
author name string	Yu Zhang Zhaohui Tang Wei Chu Qing Cai Ning Ding Haibing He Jinlong Li Jingxin Gou Pengqian Tian Tian Yin Xuezhi Zhuo
rdfs:label	Improving Plasma Stability and Bioavailability In Vivo of Gemcitabine Via Nanoparticles of mPEG-PLG-GEM Complexed with Calcium Phosphate (en) Improving Plasma Stability and Bioavailability In Vivo of Gemcitabine Via Nanoparticles of mPEG-PLG-GEM Complexed with Calcium Phosphate (nl)
skos:prefLabel	Improving Plasma Stability and Bioavailability In Vivo of Gemcitabine Via Nanoparticles of mPEG-PLG-GEM Complexed with Calcium Phosphate (en) Improving Plasma Stability and Bioavailability In Vivo of Gemcitabine Via Nanoparticles of mPEG-PLG-GEM Complexed with Calcium Phosphate (nl)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software